Autori: Tesch Hans
| Naslov | Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study (Article) |
| Autori | Kolberg Hans-Christian Colleoni Marco A Demetriou Georgia Savva Santi Patricia Xavier Tesch Hans Fujiwara Yasuhiro Tomasevic Zorica I  Hanes Vladimir
|
| Info | DRUG SAFETY, (2020), vol. 43 br. 3, str. 233-242 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Lilac Study (Meeting Abstract) |
| Autori | Kolberg Hans-Christian Colleoni Marco A Sawa-Demetriou G Santi Patricia Xavier Tesch Hans Fujiwara Yasuhiro Tomasevic Zorica I Hanes Vladimir
|
| Info | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, (2019), vol. 29 br. , Suppl. 4, str. A55-A55 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Cardiac safety of the trastuzumab biosimilar ABP 980 in women with HER2-positive early breast cancer in the LILAC study. (Meeting Abstract) |
| Autori | Kolberg Hans-Christian Colleoni Marco A Demetriou Georgia Savva Santi Patricia Xavier Tesch Hans Fujiwara Yasuhiro Tomasevic Zorica I Hanes Vladimir
|
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2019), vol. 37 br. 15, Suppl. S, str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Matching the critical function of the biosimilar ABP 980 and trastuzumab: Totality of evidence and scientific justification for extrapolation across trastuzumab indications (Meeting Abstract) |
| Autori | Kolberg Hans-Christian Colleoni Marco A Tomasevic Zoran M Ponomarova O McBride HJ Tesch Hans Hanes Vladimir |
| Info | CANCER RESEARCH, (2019), vol. 79 br. 4, Suppl. S, str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Clinical comparison of the biosimilar ABP 980 and trastuzumab in early breast cancer: Results of the phase 3 LILAC study and justification for extrapolation across approved trastuzumab indications (Meeting Abstract) |
| Autori | Kolberg Hans-Christian Tomasevic Zoran M Demetriou Georgia S von Minckwitz Gunter Fujiwara Yasuhiro Ponomarova O Tesch Hans Santi Patricia Xavier Hanes Vladimir |
| Info | EUROPEAN JOURNAL OF CANCER, (2018), vol. 92 br. , Suppl. 3, str. S103-S104 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
